{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T21:19:42Z","timestamp":1782595182946,"version":"3.54.5"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>This Viewpoint discusses the use of buprenorphine to treat cancer pain and difficulties in affordability and access despite its efficacy and safety compared with full-agonist opioids.<\/jats:p>","DOI":"10.1001\/jamaoncol.2025.1337","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:30:46Z","timestamp":1749123046000},"page":"825","source":"Crossref","is-referenced-by-count":6,"title":["Buprenorphine for Cancer Pain\u2014The Safest Opioid, and Patients With Cancer Cannot Get It"],"prefix":"10.1001","volume":"11","author":[{"given":"Amy A.","family":"Case","sequence":"first","affiliation":[{"name":"Department of Supportive and Palliative Care, Roswell Park Comprehensive Cancer Center, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellar P.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Levine Cancer Institute, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Chwistek","sequence":"additional","affiliation":[{"name":"College of Public Health, Temple University, Philadelphia, Pennsylvania"},{"name":"Supportive Oncology and Palliative Care Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali J.","family":"Zarrabi","sequence":"additional","affiliation":[{"name":"Division of Palliative Medicine, Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"cvp250014r1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jad.2015.05.049","article-title":"Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain.","volume":"184","author":"Smith","year":"2015","journal-title":"J Affect Disord"},{"issue":"2","key":"cvp250014r2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/SPC.0000000000000333","article-title":"Opioid addiction, diversion, and abuse in chronic and cancer pain.","volume":"12","author":"Kata","year":"2018","journal-title":"Curr Opin Support Palliat Care"},{"key":"cvp250014r3","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2021.691720","article-title":"Opioid therapy in cancer patients and survivors at risk of addiction, misuse or complex dependency.","volume":"2","author":"Pergolizzi","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"issue":"6","key":"cvp250014r4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/imj.13449","article-title":"Opioid addiction and misuse in adult and adolescent patients with cancer.","volume":"47","author":"Pinkerton","year":"2017","journal-title":"Intern Med J"},{"issue":"12","key":"cvp250014r5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11864-021-00910-8","article-title":"Treating chronic pain with buprenorphine\u2014the practical guide.","volume":"22","author":"Case","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"cvp250014r6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/NJH.0000000000000598","article-title":"Buprenorphine use in palliative care.","volume":"21","author":"Jones","year":"2019","journal-title":"J Hosp Palliat Nurs"},{"issue":"1","key":"cvp250014r7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/jpm.2022.0399","article-title":"Top ten tips palliative care clinicians should know about buprenorphine.","volume":"26","author":"Neale","year":"2023","journal-title":"J Palliat Med"},{"issue":"7","key":"cvp250014r8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5055\/jom.2021.0639","article-title":"Emerging pharmacologic mechanisms of buprenorphine to explain experience of analgesia versus adverse effects.","volume":"17","author":"Bettinger","year":"2021","journal-title":"J Opioid Manag"},{"issue":"5","key":"cvp250014r9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10571-020-01013-y","article-title":"Oxycodone in the opioid epidemic: high \u2018liking\u2019, \u2018wanting\u2019, and abuse liability.","volume":"41","author":"Kibaly","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"cvp250014r10","unstructured":"Purdue Pharma. New study explores nalmefene and naloxone for reversal of respiratory depression induced by fentanyl in a clinical opioid induced respiratory depression model. October 28, 2024. Accessed March 3, 2025. https:\/\/www.purduepharma.com\/news\/2024\/10\/28\/new-study-explores-nalmefene-and-naloxone-for-reversal-of-respiratory-depression-induced-by-fentanyl-in-a-clinical-opioid-induced-respiratory-depression-model\/"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2835046\/jamaoncology_case_2025_vp_250014_1755187148.9292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:00:49Z","timestamp":1755788449000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2835046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2025.1337","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}